Z Gastroenterol 2025; 63(08): e367-e368 DOI: 10.1055/s-0045-1810636
Abstracts | DGVS/DGAV
Freie Vorträge
Efficacy and safety of Xyloglucan (XG), pea protein and tannins (PPT), and Xylo-oligosaccharides
(XOS) for diarrhoea-predominant irritable bowel syndrome: a randomised, crossover
clinical trial
Authors
S Bradic
1
Reckitt Benckiser Deutschland GmbH, Medical Affairs DACH, Heidelberg, Deutschland
W Malik
2
Reckitt Benckiser Healthcare UK Ltd., Slough, UK, Medical Affairs, Slough, Vereinigtes
Königreich
J Wray
2
Reckitt Benckiser Healthcare UK Ltd., Slough, UK, Medical Affairs, Slough, Vereinigtes
Königreich
